These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28165814)

  • 1. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy.
    Li SJ; Wang XJ; Hu JB; Kang XQ; Chen L; Xu XL; Ying XY; Jiang SP; Du YZ
    Drug Deliv; 2017 Nov; 24(1):402-413. PubMed ID: 28165814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy.
    Jiang S; Li S; Hu J; Xu X; Wang X; Kang X; Qi J; Lu X; Wu J; Du Y; Xiao Y
    Nanomedicine; 2019 Jan; 15(1):25-36. PubMed ID: 30193816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
    Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
    J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Simvastatin Loaded Nanostructured Lipid Carriers and Its Therapeutic Effect on Patients with Severe Acute Lung Injury.
    Yan X; Zhang W; Cheng X; Hou L
    J Nanosci Nanotechnol; 2021 Feb; 21(2):1184-1189. PubMed ID: 33183460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats.
    Harisa GI; Alomrani AH; Badran MM
    Eur J Pharm Sci; 2017 Jan; 96():62-71. PubMed ID: 27613383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S; Ishak RAH; Hathout RM; Mortada ND
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted-lung delivery of bardoxolone methyl using PECAM-1 antibody-conjugated nanostructure lipid carriers for the treatment of lung inflammation.
    He JX; Zhu CQ; Liang GF; Mao HB; Shen WY; Hu JB
    Biomed Pharmacother; 2024 Sep; 178():116992. PubMed ID: 39106709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of VCAM-1-targeted nanostructured lipid carriers for delivery of melatonin against acute lung injury through SIRT1/NLRP3 mediated pyroptosis signaling pathway.
    Jin JB; Li J; Wang HB; Hu JB; Yang CL
    Int J Biol Macromol; 2024 May; 266(Pt 1):130637. PubMed ID: 38490396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Layer-by-Layer Assembled Nanostructured Lipid Carriers for CD-44 Receptor-Based Targeting in HIV-Infected Macrophages for Efficient HIV-1 Inhibition.
    Mahajan K; Rojekar S; Desai D; Kulkarni S; Bapat G; Zinjarde S; Vavia P
    AAPS PharmSciTech; 2021 Jun; 22(5):171. PubMed ID: 34100170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells.
    Varshosaz J; Jandaghian S; Mirian M; Sajjadi SE
    J Liposome Res; 2021 Mar; 31(1):64-78. PubMed ID: 32138557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
    Guo S; Zhang Y; Wu Z; Zhang L; He D; Li X; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109225. PubMed ID: 31325705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
    Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.
    Galvão JG; Santos RL; Silva ARST; Santos JS; Costa AMB; Chandasana H; Andrade-Neto VV; Torres-Santos EC; Lira AAM; Dolabella S; Scher R; Kima PE; Derendorf H; Nunes RS
    Eur J Pharm Sci; 2020 Jul; 150():105335. PubMed ID: 32272211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.